US Patent Issued to SYNERGENE THERAPEUTICS, GEORGETOWN UNIVERSITY on April 15 for "Methods for reducing side effects of immunotherapy" (Maryland Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,784, issued on April 15, was assigned to SYNERGENE THERAPEUTICS INC. (Potomac, Md.) and GEORGETOWN UNIVERSITY (Washington).

"Methods for reducing side effects of immunotherapy" was invented by Esther H. Chang (Potomac, Md.), Joe B. Harford (Potomac, Md.) and Sang Soo Kim (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention provides methods to overcome the current limitations of immune checkpoint immunotherapy to provide more effective methods of treating cancer. In embodiments this invention provides a means of using of p53 gene therapy to augment immune checkpoint inhibition by combining antibodies targeting immune checkpoin...